MET and hepatocellular carcinoma: Pre-clinical studies have shown both pro- and anti-tumorigenic roles for the HGF/c-MET pathway in HCC (166–169), and analysis of clinical samples suggests an overall decreased expression of HGF in adult HCC (160).